DOPAMINE AGONISTS

Novel compounds which are selective dopamine agonists are useful for treating disorders characterized by abnormal dopamine levels, such as Parkinson's Disease, as well as cardiovascular disorders.

Saved in:
Bibliographic Details
Main Authors RICHARD J. PERNER, JAMES R. CAMPBELL, MICHAEL P. DENINNO, PAUL P. EHRLICH, JOHN F. DEBERNARDIS, LINDA M. LIJEWSKI, ROBERT W. SCHOENLEBER, DAVID M. STOUT, YVONNE C. MARTIN, JOHN W. KEBABIAN, STANLEY DIDOMENICO JR, CHI-NUNG W. HSIAO, BISWANATH DE, HOWARD E. MORTON, FATIMA Z. BASHA, MICHEAL D. MEYER
Format Patent
LanguageEnglish
Published 07.01.1991
Edition5
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Novel compounds which are selective dopamine agonists are useful for treating disorders characterized by abnormal dopamine levels, such as Parkinson's Disease, as well as cardiovascular disorders.
Bibliography:Application Number: AU19900058182